Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 348
Last updated 2021-11-29
Summary
This is a prospective, single-center, non-randomized, non-controlled observational study.
Conditions
Sponsors & Collaborators
-
Peking University
lead OTHER
Principal Investigators
-
Qi-jun Zheng, MD · Peking University Cancer Hospital & Institute
Eligibility
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-22
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- China
Study Locations
More Related Trials
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive
NCT01668914 ·Status: COMPLETED ·Phase: PHASE3
-
Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)
NCT04156841 ·Status: UNKNOWN
-
Sentinel Node Biopsy Vs Observation After Axillary PET
NCT04072653 ·Status: RECRUITING ·Phase: NA
-
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142 ·Status: UNKNOWN ·Phase: NA
-
Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Initial cN1 Breast Cancer
NCT06518135 ·Status: RECRUITING
-
Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
NCT00909441 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
NCT03556397 ·Status: COMPLETED ·Phase: NA
-
The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes
NCT02005926 ·Status: COMPLETED ·Phase: PHASE2
-
Omission of SLNB in CN0 Early Breast Cancer
NCT05935150 ·Status: RECRUITING ·Phase: NA
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
NCT07080944 ·Status: RECRUITING ·Phase: NA
-
Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer
NCT06149377 ·Status: COMPLETED
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN
-
Axillary Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph Nodes
NCT02612012 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
NCT03255577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer
NCT05141630 ·Status: UNKNOWN ·Phase: PHASE2
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients
NCT03606616 ·Status: COMPLETED
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
NCT04826211 ·Status: COMPLETED ·Phase: NA
-
Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm
NCT00636467 ·Status: COMPLETED ·Phase: PHASE2
-
Axillary Staging in Early Breast Cancer: SNB vs PET/MRI
NCT04829643 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
NCT00005821 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"
NCT04930692 ·Status: UNKNOWN ·Phase: NA
-
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
NCT06001528 ·Status: RECRUITING
-
Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients
NCT00507611 ·Status: COMPLETED ·Phase: NA